Gemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (mbc), a phase ii study
By: al-Serafi, Mustafa M.; al-Khudari, Ahmad; Mansur, Usman M.…[et al.]. Journal of the Egyptian National Cancer Institute. Vol. 18, no. 3 (Sep. 2006), pp.209-215, 7 p.
Subjects: Antineoplastic drugs; Breast; Cancer